Status:
UNKNOWN
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Lead Sponsor:
University Hospital, Rouen
Conditions:
Hepatitis B
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
Eligibility Criteria
Inclusion
- Former or active intravenous and/or nasal drug user
- Person on opiate substitution therapy
Exclusion
- Person with known active viral infection(s)
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05390424
Start Date
June 1 2022
End Date
September 1 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CSAPA la Boussole
Rouen, France